The Onco’Zine Brief

Peter Hofland talks with Dr. Greg Van Wyk, Chief Executive Officer and Chief Medical Officer of Noxopharm who has developed a drug that specifically target cancer cells, rendering them less able to survive radiotherapy

  • IMG_9403 copy
    Peter Hofland, Ph.D
  • YL20_HealthRadioBanner_940x118px
  • Website Banner Jon Mason 1
  • aht-biohealthtech-ht
  • the q3
  • banner-ukhr-940x118-001
  • Feeling low Boom Back
  • creator
  • AD-resize
  • Kidney Contenders Logo